• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩帕金森变异型的早期筛查:一个六项评分系统

Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item Score.

作者信息

Fanciulli Alessandra, Stankovic Iva, Avraham Omer, Jecmenica Lukic Milica, Ezra Adi, Leys Fabian, Goebel Georg, Krismer Florian, Petrovic Igor, Svetel Marina, Seppi Klaus, Kostic Vladimir, Giladi Nir, Poewe Werner, Wenning Gregor K, Gurevich Tanya

机构信息

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Neurology Clinic, University Clinical Center of Serbia, Belgrade, Serbia.

出版信息

Mov Disord Clin Pract. 2024 Apr 24;11(7):867-73. doi: 10.1002/mdc3.14048.

DOI:10.1002/mdc3.14048
PMID:38659282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11233846/
Abstract

BACKGROUND

A 4-item score based on ≥2 features out of orthostatic hypotension, overactive bladder, urinary retention and postural instability was previously shown to early distinguish the Parkinson-variant of multiple system atrophy (MSA-P) from Parkinson's disease (PD) with 78% sensitivity and 86% specificity.

OBJECTIVES

To replicate and improve the 4-item MSA-P score.

METHODS

We retrospectively studied 161 patients with early parkinsonism [ie, ≤2 years disease duration or no postural instability, aged 64 (57; 68) years, 44% females] and a diagnosis of clinically established MSA-P (n = 38) or PD (n = 123) after ≥24 months follow-up.

RESULTS

The 4-item MSA-P score had a 92% sensitivity and 78% specificity for a final MSA-P diagnosis. By including dopaminergic responsiveness and postural deformities into a 6-item score (range: 0-6), reaching ≥3 points at early disease identified MSA-P patients with 89% sensitivity and 98% specificity.

CONCLUSIONS

The 6-item MSA-P score is a cost-effective tool to pinpoint individuals with early-stage MSA-P.

摘要

背景

基于直立性低血压、膀胱过度活动症、尿潴留和姿势性不稳中≥2项特征的4项评分,先前已显示能早期区分多系统萎缩帕金森型(MSA-P)和帕金森病(PD),敏感性为78%,特异性为86%。

目的

复制并改进4项MSA-P评分。

方法

我们回顾性研究了161例早期帕金森病患者[即病程≤2年或无姿势性不稳,年龄64(57;68)岁,44%为女性],在随访≥24个月后确诊为临床确诊的MSA-P(n = 38)或PD(n = 123)。

结果

4项MSA-P评分对最终MSA-P诊断的敏感性为92%,特异性为78%。通过将多巴胺能反应性和姿势畸形纳入6项评分(范围:0 - 6),疾病早期达到≥3分可识别出MSA-P患者,敏感性为89%,特异性为98%。

结论

6项MSA-P评分是一种经济有效的工具,可精准识别早期MSA-P患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef95/11233846/8a3e164d8d88/MDC3-11-867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef95/11233846/8a3e164d8d88/MDC3-11-867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef95/11233846/8a3e164d8d88/MDC3-11-867-g001.jpg

相似文献

1
Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item Score.多系统萎缩帕金森变异型的早期筛查:一个六项评分系统
Mov Disord Clin Pract. 2024 Apr 24;11(7):867-73. doi: 10.1002/mdc3.14048.
2
Comparison of gait parameters between drug-naïve patients diagnosed with multiple system atrophy with predominant parkinsonism and Parkinson's disease.与帕金森病患者相比,初诊为多系统萎缩伴帕金森综合征患者的步态参数比较。
Parkinsonism Relat Disord. 2019 Mar;60:87-91. doi: 10.1016/j.parkreldis.2018.09.018. Epub 2018 Sep 17.
3
Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension.皮肤活组织检查有助于区分直立性低血压伴帕金森病样多系统萎缩。
Mov Disord. 2020 Sep;35(9):1649-1657. doi: 10.1002/mds.28126. Epub 2020 Jun 18.
4
Supine hypertension in Parkinson's disease and multiple system atrophy.帕金森病和多系统萎缩中的仰卧位高血压
Clin Auton Res. 2016 Apr;26(2):97-105. doi: 10.1007/s10286-015-0336-4. Epub 2016 Jan 22.
5
Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage.采用新型综合仪器方法进行的心血管自主神经测试有助于在早期将帕金森叠加综合征与帕金森病区分开来。
Parkinsonism Relat Disord. 2015 May;21(5):477-82. doi: 10.1016/j.parkreldis.2015.02.011. Epub 2015 Feb 21.
6
Prospective study of relevance of I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson's disease and multiple system atrophy.前瞻性研究 I-MIBG 心肌闪烁显像和可乐定 GH 试验对帕金森病和多系统萎缩的相关性。
J Neurol. 2018 Sep;265(9):2033-2039. doi: 10.1007/s00415-018-8941-5. Epub 2018 Jun 28.
7
Twenty-four-hour ambulatory blood pressure and heart rate profiles in diagnosing orthostatic hypotension in Parkinson's disease and multiple system atrophy.24小时动态血压和心率曲线在帕金森病和多系统萎缩直立性低血压诊断中的应用
Eur J Neurol. 2017 Jan;24(1):90-97. doi: 10.1111/ene.13135. Epub 2016 Oct 7.
8
The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism.复合自主神经症状量表31是帕金森综合征患者的一种有用的筛查工具。
PLoS One. 2017 Jul 6;12(7):e0180744. doi: 10.1371/journal.pone.0180744. eCollection 2017.
9
[Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].[帕金森病和多系统萎缩患者红细胞寡聚α-突触核蛋白的改变]
Zhonghua Yi Xue Za Zhi. 2023 Oct 10;103(37):2933-2939. doi: 10.3760/cma.j.cn112137-20230607-00957.
10
The differences of orthostatic hypotension in patients with Parkinson's disease and multiple system atrophy.帕金森病和多系统萎缩患者直立性低血压的差异。
Front Neurol. 2023 Jan 26;14:1070943. doi: 10.3389/fneur.2023.1070943. eCollection 2023.

引用本文的文献

1
Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology.帕金森病自主神经功能衰竭、疼痛及睡眠障碍的诊断与治疗:德国神经病学学会“帕金森病”指南
J Neurol. 2025 Jan 3;272(1):90. doi: 10.1007/s00415-024-12730-5.

本文引用的文献

1
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria.帕金森病的生物学分类:SynNeurGe 研究诊断标准。
Lancet Neurol. 2024 Feb;23(2):191-204. doi: 10.1016/S1474-4422(23)00404-0.
2
Validation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank.梅奥诊所脑库中多系统萎缩诊断的MDS标准验证研究
Neurology. 2023 Dec 12;101(24):e2460-e2471. doi: 10.1212/WNL.0000000000207905. Epub 2023 Oct 10.
3
Pathological Validation of the MDS Criteria for the Diagnosis of Multiple System Atrophy.
多系统萎缩诊断的MDS标准的病理学验证
Mov Disord. 2023 Mar;38(3):444-452. doi: 10.1002/mds.29304. Epub 2023 Jan 6.
4
Clinical autonomic nervous system laboratories in Europe: A joint survey of the European Academy of Neurology and the European Federation of Autonomic Societies: A joint survey of the European Academy of Neurology and the European Federation of Autonomic Societies.欧洲临床自主神经系统实验室:欧洲神经病学学会和欧洲自主神经学会联合会的联合调查。
Eur J Neurol. 2022 Dec;29(12):3633-3646. doi: 10.1111/ene.15538. Epub 2022 Sep 20.
5
A call for multiple system atrophy centers of excellence.呼吁建立多系统萎缩卓越中心。
Clin Auton Res. 2022 Jun;32(3):205-208. doi: 10.1007/s10286-022-00866-1. Epub 2022 May 12.
6
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?多系统萎缩的疾病修饰治疗:2022 年我们处于什么阶段?
J Parkinsons Dis. 2022;12(5):1369-1387. doi: 10.3233/JPD-223183.
7
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.运动障碍学会多系统萎缩诊断标准。
Mov Disord. 2022 Jun;37(6):1131-1148. doi: 10.1002/mds.29005. Epub 2022 Apr 21.
8
Validation of the Neurogenic Orthostatic Hypotension Ratio with Active Standing.主动站立时神经源性直立性低血压比值的验证
Ann Neurol. 2020 Sep;88(3):643-645. doi: 10.1002/ana.25834. Epub 2020 Jul 14.
9
Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study.帕金森病中的姿势异常:一项流行病学和临床多中心研究
Mov Disord Clin Pract. 2019 Jun 29;6(7):576-585. doi: 10.1002/mdc3.12810. eCollection 2019 Sep.
10
The Schellong test: detecting orthostatic blood pressure and heart rate changes in German-speaking countries.谢隆试验:在德语国家检测直立性血压和心率变化。
Clin Auton Res. 2019 Aug;29(4):363-366. doi: 10.1007/s10286-019-00619-7. Epub 2019 Jul 4.